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Abstract
Background: A randomized controlled trial examining the efficacy of behavior therapy for pediatric trichotillomania 
was recently completed with 24 participants ranging in age from 7 - 17. The broad age range raised a question about 
whether young children, older children, and adolescents would respond similarly to intervention. In particular, it is 
unclear whether the younger children have the cognitive capacity to understand concepts like "urges" and whether 
they are able to introspect enough to be able to benefit from awareness training, which is a key aspect of behavior 
therapy for trichotillomania.
Methods: Participants were randomly assigned to receive either behavior therapy (N = 12) or minimal attention 
control (N = 12), which was included to control for repeated assessments and the passage of time. Primary outcome 
measures were the independent evaluator-rated NIMH-Trichotillomania Severity Scale, a semi-structured interview 
often used in trichotillomania treatment trials, and a post-treatment clinical global impression improvement rating 
(CGI-I).
Results: The correlation between age and change in symptom severity for all patients treated in the trial was small and 
not statistically significant. A 2 (group: behavioral therapy, minimal attention control) × 2 (time: week 0, 8) × 2 (children 
< 9 yrs., children > 10) ANOVA with independent evaluator-rated symptom severity scores as the continuous 
dependent variable also detected no main effects for age or for any interactions involving age. In light of the small 
sample size, the mean symptom severity scores at weeks 0 and 8 for younger and older patients randomized to 
behavioral therapy were also plotted. Visual inspection of these data indicated that although the groups appeared to 
have started at similar levels of severity for children ≤ 9 vs. children ≥ 10; the week 8 data show that the three younger 
children did at least as well as if not slightly better than the nine older children and adolescents.
Conclusions: Behavior therapy for pediatric trichotillomania appears to be efficacious even in young children. The 
developmental and clinical implications of these findings will be discussed.
Trial Registration: Clinicaltrials.gov NCT00043563.
Background
Trichotillomania (TTM) is a chronic impulse-control dis-
order in which the individual pulls out one's hair to the
point of alopecia. TTM is estimated to affect 1% - 3.5% of
late adolescents and young adults [1]; rates among
younger children are largely unknown [2]. Sufferers of
TTM across the developmental spectrum may experience
medical complications such as skin irritation, infections
and repetitive use hand injuries [3]; those who ingest the
hairs after pulling are at risk for gastrointestinal compli-
cations stemming from trichobezoars (i.e., hairballs);
[4,5]), which have been documented in patients as young
as four [6]. Psychiatric comorbidity is apparently com-
mon, and includes anxiety disorders, mood disorders,
substance use disorders, eating disorders [6,7], and per-
sonality disorders in adults [8] and anxiety and disruptive
behavior disorders in youth [9,2]. Notably, TTM onset in
childhood or adolescence appears to be the norm, and
TTM onset typically precedes that of most comorbidities
[10]. Accordingly, a major priority in TTM psychopathol-
ogy and treatment research is to recruit younger samples
since clinical trials have enrolled children with TTM as
young as seven, so we know that they can participate, if
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not do well, with Habit and Reversal Training (HRT) [11].
The goal of improving our understanding of TTM closer
i n t im e  t o its  onset  will  pe r ha ps,  by e x t e ns ion,  r educ e
future functional impairment and prevent the develop-
ment of debilitating comorbid disorders.
Despite the fact that TTM is a pediatric onset disorder
associated with significant morbidity, comorbidity, and
functional impairment in adults [12], very few TTM psy-
chopathology research studies have actually included
adolescents or children, and there are as yet no published
randomized controlled trials (RCTs) of any psychophar-
macological interventions for youth with TTM. Initial
findings for cognitive-behavioral therapy were encourag-
ing [13], but questions pertaining to the role of develop-
mental factors in TTM psychopathology and treatment
response have yet to be examined. With respect to simi-
larities and differences in TTM presentation across
development, very little is known about symptom presen-
tation in young children, but it appears that the scalp is
the most common pulling site in both adults and older
children and adolescents [7,14,2,15]. Pulling tends to be
both automatic (i.e., outside awareness) and focused (i.e.,
in response to identifiable affective triggers) within each
individual, rather than exclusively one form or the other
[16,17] although it appears that there is a greater prepon-
derance of automatic pulling in younger samples. The
concept of urge plays an important role, as most partici-
pants in TTM studies to date have reported tension or
some other unpleasant sensation that precedes pulling
[12]. Whether urges are present or can be reliably
described by younger patients with TTM is unknown,
although one study among youth and adults with tic dis-
orders [18] found that while adults were able to identify
and verbalize both the premonitory urge to tic and the
relief experienced after indulging that impulse, children
under age 10 were unable to describe the premonitory
urge reliably. Perhaps young children have not yet devel-
oped the expressiveness skills and emotional awareness
[19] required in behavior therapy for TTM, so it is
unclear if young children would actually benefit from
such treatments. Further, as Freeman et al.'s [19] research
demonstrated among young children with OCD, very
young participants may lack the insight, motivation, and
developmental capacity to follow a treatment protocol on
their own, so the protocol may need to be altered to bet-
ter suit these developmental needs and to set the treat-
ment in the context of the family.
Following from Freeman et al.'s [19] work, we wish to
examine whether the developmental issues described
above necessarily preclude the use of child-focused HRT
in the treatment of young children with TTM. For the
reasons outlined above, we believe that HRT designed for
older children and adolescents with TTM will yield the
same gains in treatment outcome when applied to young
children. Further, given that there are no prior published
randomized trials for any treatment for pediatric TTM
and that there is a paucity of information available about
TTM psychopathology and treatment outcome in
younger children with TTM, data in the current report
are being used solely for the purposes of hypothesis gen-
eration.
Methods
Participants
Participants were recruited into a randomized controlled
trial examining the efficacy of behavior therapy for pedi-
atric TTM that was conducted at the University of Penn-
sylvania's School of Medicine. Primary inclusion criteria
for that study were: 1) ages 7 -17 inclusive; 2) diagnosis of
TTM; 3) symptom duration of at least six months; and 4)
participant and at least one parent fluent in English. Pri-
mary exclusion criteria were: 1) a primary psychiatric
diagnosis other than TTM; 2) current bipolar illness,
developmental disorder, or thought disorder; and 3) cur-
rently receiving either pharmacotherapy or concomitant
psychotherapy for TTM. Written informed consent was
obtained from all participants for publication of this
manuscript and accompanying images. A copy of the
written consent is available for review by the Editor-in-
Chief of this journal. Twenty-four patients were random-
ized, 12 to each condition. The sample ranged in age from
7 - 17, with a mean age of 12.5 (2.7); 4 of the 24 partici-
pants (17%) were ≤ 9 years old, with 3 of those partici-
pants randomized to BT. The sample was primarily
Caucasian (75%), primarily female (67%), and had a mean
age of TTM onset of 8.9 years (3.2). Additional informa-
tion about participants randomized to BT can be found
in Table 1. Notably, all 24 patients completed the acute
phase (week 8) of treatment, and all 12 patients random-
ized to BT completed the 8-week maintenance phase.
Table 1: Duration of Pulling, Age of Onset and Number with Comorbidity in Those Assigned to Behavioral Therapy
Average Duration of Pulling 
(years)
Average Age of Onset 
(years)
Percentage with 
Comorbidity
Children ≤ 9 (N = 3) 3.0 (SD = 2.6) 5.3 (SD = 2.1) 33%
Children > 9 (N = 9) 4.0 (SD = 2.3) 8.4 (SD = 3.9) 33%Franklin et al. Child and Adolescent Psychiatry and Mental Health 2010, 4:18
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Because all MAC patients were offered open BT at week
8 on ethical grounds, no data on MAC are available
through the maintenance phase of the study. Only data
from the acute phase of the study will be presented in the
current report.
Measures
Diagnostic criteria for TTM were assessed using the Tri-
chotillomania Diagnostic Interview (TDI) [20], which
examined TTM diagnosis according to DSM-IV criteria;
notably, as in other studies of TTM, Criterion B (tension
prior to pulling) and Criterion C (gratification/relief fol-
lowing pulling) were evaluated yet not required for study
entry. Diagnostic criteria for other psychiatric disorders
were surveyed using the Anxiety Disorders Interview
Schedule for Children (ADIS-C) [21], a semi-structured
interview with established psychometric properties. The
TDI and ADIS-C were used to assess diagnostic inclusion
criteria, and were conducted at intake by evaluators
trained to criteria in their use. The primary measure of
treatment outcome was the NIMH Trichotillomania
Severity Scale (NIMH-TSS) [22], which has demon-
strated adequate psychometric properties in prior studies
of TTM treatment [see [23]]. The NIMH-TSS ranges
from 0 (no symptoms) to 25 (severe symptoms), and sur-
veys time spent pulling in the past week, time spent pull-
ing the previous day, resistance to pulling, associated
distress, and functional impairment. Trained indepen-
dent evaluators blind to treatment assignment conducted
the NIMH-TSS interviews at weeks 0, 4, and 8 during the
acute phase of the trial; the same evaluator conducted
assessments throughout the trial to minimize interviewer
effects. A Clinical Global Impression - Improvement
(CGI-I) score was also rated at week 8 by the same blind
evaluator; this scale ranged from 1 (much worse) to 7
(much better), with a score of 4 indicating no change in
symptoms from baseline. Only data from weeks 0 (base-
line) and 8 (post-treatment) assessments are presented in
the current report.
Treatments
Behavior therapy was conducted in accordance with a
manual developed in the context of a treatment develop-
ment grant; this manual has now been published [24].
The acute treatment phase for behavior therapy lasted
eight weeks and was conducted weekly; core elements of
treatment included: 1) psychoeducation about the nature
and treatment of TTM; 2) awareness training, in which
participants were taught to become more aware of pulling
behavior and pulling urges; 3) stimulus control, in which
barriers to pulling were created based on participants'
report of high-risk situations; and 4) competing response
training, in which participants were taught to engage in
behaviors that were physically incompatible with pulling.
Ancillary strategies were also permitted and included:
progressive muscle relaxation (Session 5) and cognitive
restructuring (Session 6); inclusion of these strategies was
discussed in weekly supervision meetings with the Princi-
pal Investigator (MEF). Minimal attention control (MAC)
was employed in this treatment development project to
control for the effects of time and of repeated assessment;
participants who received MAC were introduced to a
therapist at week 0 and met again with the therapist at
weeks 4 and 8. Notably, MAC did not match BT in the
amount of clinical contact, nor was it intended to be an
active intervention. Accordingly, MAC participants were
offered open BT at week 8, thus no comparisons of BT
a n d  MA C  w e r e  pos s i b l e  bey o n d  w ee k  8 .  P ri m a ry  o u t -
comes for the comparison of BT versus MAC are pre-
sented elsewhere [11] but indicated a clear advantage for
BT over MAC following acute treatment.
Statistical Methods
Study data were examined using three main approaches.
First, the correlation between participants' age and
change in TTM symptoms over the course of treatment
was calculated. Second, combined plots were created to
permit visual inspection of response trends between the
older (≥ 10) and younger (≤ 9) participants; this dichot-
omy was selected based on data from Tourette Syndrome
indicating that children ages 9 and lower have more diffi-
culty reliably reporting on concepts such as urges [see
[18]]. Along with this standard, single-subject approach
to data analysis, an exploratory, mixed repeated-mea-
sures analysis of variance (ANOVA) was conducted to
test for differences between the older and younger groups
in IE-rated TTM severity over time. The NIMH-TSS pre-
treatment distribution of scores appeared to be normal
b u t,  as  is  o ft e n  t h e  case  i n  c l i n i ca l  t r ia ls  i n  w h i c h  t h e
treatments are active, there was some evidence of nega-
tive skew in the distribution at post-treatment; neverthe-
less, ANOVAs were conducted to help better
contextualize study findings against the broader literature
on TTM. Notably, the current study was not powered to
conduct traditional significance testing across multiple
dependent measures, hence the exclusive focus on the
study's primary continuous outcome measure, the blind
IE-rated NIMH TSS scores.
Results and Discussion
Correlation between Age and Change in TTM Symptoms
The correlation between age and change in TTM symp-
toms (NIMH-TSS total score at week 0 - week 8) for all 24
participants in the RCT was -.16, which was not signifi-
cant statistically (p  = .48) and not supportive of an
expected association between age and change in TTM
symptom severity over time regardless of treatment
received.Franklin et al. Child and Adolescent Psychiatry and Mental Health 2010, 4:18
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Group by Time Effects
A 2 (condition: BT, MAC) × 2 (time: week 0, 8) × 2 (age
group: children ≤ 9 yrs., children ≥ 10) ANOVA was con-
ducted, with IE-rated NIMH- TSS scores as the depen-
dent variable. No main effect for age was detected, nor
did any interactions involving age emerge (all Fs < 1.0).
Nevertheless, because children ≤ 9 comprised only 17% of
the sample, statistical power to detect differences is
inherently limited. Although statistical comparisons were
not conducted, data on percentages of those with
improved or very much improved CGI-I scores are pre-
sented in Table 2.
Visual Inspection of Plotted NIMH-TSS Data
In order to further explore the possible influence of
developmental factors on behavior therapy outcomes
specifically, all NIMH-TSS scores at weeks 0 and 8 for
younger and older patients randomized to BT were plot-
ted and visually inspected as evident in Additional File 1
(Figure 1), and the mean NIMH-TSS scores at pre and
post-treatment for both age groups are presented in
Additional File 2 (Figure 2). Although, NIMH-TSS scores
at week 0 appear to be quite similar ((M = 12.7 (4.0) for
children ≤ 9 vs. M = 11.2 (2.3) for children ≥ 10)) and the
within-subjects effect sizes for both groups were very
large (see Table 2), the week 8 data suggests that the three
younger children ((M = 0.7 (1.9)) did at least as well as if
not slightly better than the nine older children and ado-
lescents ((M = 4.4, (1.4)), although developmental issues
such as ability to understand evaluators' questions about
urges and recall pulling behavior over the course of the
past week may decrease confidence in the outcomes for
the young children.
Conclusions
The purpose of the current report was to explore whether
developmental factors influenced change in TTM symp-
toms in a pediatric sample randomly assigned to receive
either behavior therapy or a comparison condition
designed to control for the effects of time and repeated
assessments. Findings indicated that there was a small,
negative, and insignificant relationship between partici-
pants' age and change in TTM symptoms over the course
of the acute phase of the trial. When a mixed ANOVA
was employed to further explore the effects of age on
treatment outcome, here again no effects for develop-
mental level emerged. Low power could have obscured
such effects, however, so inspection of behavior therapy
outcomes specifically was warranted in order to generate
hypotheses about whether the youngest participants
might have experienced attenuated outcomes relative to
their older counterparts. The behavior therapy protocol
for TTM includes techniques that require at least some
ability to introspect (e.g., awareness training), and the tai-
loring of subsequent treatment strategies such as stimu-
lus control and competing response training rest upon
increased awareness of the presence of urges to pull. Our
data here were somewhat surprising given initial con-
cerns about the ability of young children to grasp these
c o r e  c o n c e p t s  i n  t h a t  t h e i r  o u t c o m e s  w e r e  c l e a r l y  n o t
attenuated, and were even suggestive of the possibility
that children age 7 - 9 might experience more success in
BT than their older counterparts.
Data emerging from cross-sectional comparisons of
TTM in different developmental stages might help
explain this seemingly anomalous observation, in that it
appears that pulling in younger children might be more
"automatic" and less affect-driven than it appears to be in
older children and in adults [16]. Younger children also
report fewer pulling sites than do older children and
adults [25], again suggesting that TTM might become
m o r e  c o m p l e x  o v e r  t i m e .  D r i v e n  b y  a c c u m u l a t i n g  ev i -
Table 2: Pre and Post Treatment NIMH-TSS Scores, NIMH-TSS Effect Sizes and Percentage Improved or Very Improved on 
the CGI-I
Pre-Treatment NIMH-
TSS Scores (M)
Post-Treatment NIMH-
TSS Scores (M)
NIMH-TSS Within-
Subjects Effects Size 
(Cohen's d)
Percentage 
Improved or Very 
Much Improved on 
the CGI
Children ≤ 9 (N = 3) 11.2 (SD = 2.3) 0.7 (SD = 1.9) 2.68 100%
Children >9 (N = 9) 12.7 (SD = 3.0) 4.4 (SD = 1.4) 1.19 67%
Figure 1 Change in NIMH-TSS Scores. This figure represents the 
change in NIMH-TSS scores from week 0 to week 8 for each of those 
participants randomized to BT
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dence that relapse is common following BT in adults [26],
current treatment development research in adult TTM
has focused recently on incorporating treatment compo-
nents to address emotions specifically [27]. What cannot
be examined using data from the current study, however,
is whether developmental factors such as inability to
i n t r o s p e c t  o r  r e p o r t  o n  c o n c e p t s  s u c h  a s  u r g e s  w o u l d
negatively impact treatment of children younger than age
7. There is now evidence in pediatric OCD indicating that
a family-based intervention involving exposure plus
response prevention for children ages 4 -8 was superior
to a relaxation control condition [19]; it may well be the
case that similar treatment development efforts in pediat-
ric TTM will permit effective intervention that can be
delivered to children even younger than those who par-
ticipated in the current study. Our findings of comparable
if not slightly better treatment outcomes for younger chil-
dren are not entirely consistent across pediatric onset dis-
orders in which urges play a prominent role such as in
Tourette Syndrome; thus, cross-diagnostic studies are
clearly needed to examine urge phenomenology and
response to behavioral treatments such as HRT in which
urge awareness may play a prominent role in signaling the
patient to engage in a competing behavior. Such efforts
are indeed underway, and will closely mirror efforts
already being made in OCD specifically to properly con-
textualize the behavioral intervention in view of develop-
mental considerations, given the misinformation about
these conditions that many families have been exposed to
prior to seeking treatment, and the deleterious interactive
effects of these conditions on family environment and on
specific family members.
All of the limitations inherent in any study with a sam-
ple size this small are applicable here as well, and thus
even our preliminary conclusions must be interpreted
with considerable caution. Nevertheless, the dearth of
published research in pediatric TTM necessitates efforts
at empirical hypothesis generation wherever possible,
which is what led to the exploration reported above. A
second randomized controlled trial funded by the
National Institute of Mental Health in the U.S. that com-
pares the efficacy of BT to a more active control condi-
tion that equates therapist contact time
(Psychoeducation/Supportive Counseling) is underway at
Penn but, unfortunately, reviewer concerns about the
developmental issues discussed above necessitated a
design decision to truncate the age range to 10 - 17. There
are very few other sources of knowledge available about
treatment efficacy for children with TTM who are
younger than age 10, and thus we felt that, despite the
obvious caveats, it was important to take the opportunity
provided by these data to help stimulate thinking about
whether and how best to intervene in young children
with TTM.
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